Get Your Personalized Supplement StackSupplement Stack Quiz

Organic Tulsi Proprietary Blend

Q: Is Tulsi safe for long-term use?

Current evidence supports safety for up to 13 weeks of use. Longer-term studies are needed to definitively confirm its safety profile beyond this period.

Q: Can Tulsi be used alongside diabetes medications?

Tulsi may have additive effects on blood sugar levels. Medical supervision is strongly recommended to monitor glucose and adjust medication if necessary.

Q: How soon can benefits be expected?

Clinical improvements are often observed within 2–4 weeks of consistent supplementation, with more pronounced effects typically seen within 2 to 13 weeks.

Q: Is the proprietary blend more effective than pure Tulsi?

There are no direct comparative studies. The effectiveness of a proprietary blend depends on its specific composition, standardization, and the quality of its ingredients.

Also known as: Ocimum tenuiflorum, Tulsi, Holy Basil, Ocimum sanctum

Overview

Tulsi, scientifically known as Ocimum sanctum or Ocimum tenuiflorum, is a revered medicinal herb native to the Indian subcontinent, deeply rooted in Ayurvedic and traditional medicine. It is classified as an adaptogen, known for its ability to help the body adapt to stress. This herb is recognized for its diverse pharmacological properties, including anti-inflammatory, antimicrobial, cardioprotective, and immunomodulatory effects. An "Organic Tulsi Proprietary Blend" typically consists of organic Tulsi leaves or extracts, often standardized for active compounds like eugenol, ursolic acid, or rosmarinic acid, and may be combined with other complementary herbs. Research on Tulsi is robust in preclinical studies and increasingly supported by human clinical trials, with a systematic review summarizing 24 human studies involving over 1000 participants, demonstrating its potential benefits across various health domains.

Benefits

Tulsi offers several evidence-based benefits, primarily in metabolic health, stress reduction, and cardiovascular support. For metabolic health, supplementation has shown significant reductions in fasting blood glucose and improvements in lipid profiles in adults with metabolic disorders, including diabetes and metabolic syndrome. These effects are supported by meta-analyses indicating moderate effect sizes (p < 0.05). As an adaptogen, Tulsi demonstrates significant effects in reducing psychological stress and improving cognitive function in clinical trials. It also exhibits cardioprotective effects, including blood pressure modulation and anti-inflammatory actions. Secondary benefits include antimicrobial and immunomodulatory properties, though these require further robust clinical validation. Clinical benefits are typically observed within 2 to 13 weeks of consistent supplementation.

How it works

Tulsi's therapeutic effects stem from its rich array of bioactive compounds, including eugenol, ursolic acid, and rosmarinic acid, which act through multiple biological pathways. It functions as a potent antioxidant by scavenging free radicals and reduces inflammation by modulating pro-inflammatory cytokines. For metabolic regulation, Tulsi enhances insulin sensitivity and positively influences lipid metabolism. Its adaptogenic and neuroprotective effects are attributed to its ability to modulate neurotransmitter systems and reduce cortisol levels, thereby helping the body manage stress. The absorption and bioavailability of these compounds can vary depending on the extract form, with aqueous and ethanolic extracts being commonly used.

Side effects

Tulsi is generally considered safe for consumption, with clinical trials involving over 1000 participants reporting no significant adverse events. The most commonly reported side effect is mild gastrointestinal discomfort, which occurs rarely (in less than 5% of cases). However, caution is advised regarding potential drug interactions. Tulsi may have additive effects with hypoglycemic medications, potentially leading to excessively low blood sugar levels, and could interact with anticoagulant medications, increasing the risk of bleeding. Due to a lack of sufficient safety data, Tulsi is not recommended for use during pregnancy and lactation. No significant contraindications have been identified in systematic reviews, but individuals on medication or with underlying health conditions should consult a healthcare professional before starting supplementation.

Dosage

Effective dosages of Tulsi in clinical trials have shown a wide range, typically from 300 mg to 3000 mg daily. The minimum effective dose is approximately 300 mg/day of Tulsi leaf extract. Optimal daily dosages often fall within the 300 mg to 3000 mg range, administered 1–3 times per day, depending on the specific extract type (aqueous, ethanolic, or whole plant material). A maximum safe dose of up to 14 g/day of whole plant aqueous extract has been reported without adverse effects. For consistent results, standardized extracts are preferred. While no specific cofactors are identified, absorption may be enhanced when taken with food. Divided doses throughout the day may optimize its therapeutic effects.

FAQs

Is Tulsi safe for long-term use?

Current evidence supports safety for up to 13 weeks of use. Longer-term studies are needed to definitively confirm its safety profile beyond this period.

Can Tulsi be used alongside diabetes medications?

Tulsi may have additive effects on blood sugar levels. Medical supervision is strongly recommended to monitor glucose and adjust medication if necessary.

How soon can benefits be expected?

Clinical improvements are often observed within 2–4 weeks of consistent supplementation, with more pronounced effects typically seen within 2 to 13 weeks.

Is the proprietary blend more effective than pure Tulsi?

There are no direct comparative studies. The effectiveness of a proprietary blend depends on its specific composition, standardization, and the quality of its ingredients.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC5376420/ – This systematic review by Jamshidi & Cohen (2017) analyzed 24 human clinical studies (n=1111) on Tulsi. It found consistent favorable effects across metabolic, cardiovascular, immune, and neurocognitive outcomes with no significant adverse events. The review highlighted heterogeneity in dosage and study durations as limitations, suggesting a moderate quality of evidence due to small sample sizes in many trials.
https://pubmed.ncbi.nlm.nih.gov/28400848/ – This is likely another access point or a related publication to the Jamshidi & Cohen (2017) systematic review. It reinforces the findings of consistent favorable effects of Tulsi across various health parameters in human clinical studies, emphasizing its adaptogenic and therapeutic potential.
https://www.semanticscholar.org/paper/Effect-of-Tulsi-(-Ocimum-sanctum-Linn.)-on-Clinical-Devra-Mathur/d77418f9d040c164442ef9a24bebc7d63e5c76cb – This source likely refers to a meta-analysis or an RCT on Tulsi's metabolic effects. It indicates significant reductions in fasting blood glucose and improvements in lipid profiles in patients with metabolic diseases, with statistically significant effect sizes. The study noted variability in extract standardization and short durations as limitations.
https://ouci.dntb.gov.ua/en/works/4NZ8pYO4/ – This source likely refers to an RCT on overweight/obese young adults. It demonstrated improvements in biochemical parameters related to metabolic health after Tulsi supplementation. The study featured an adequate sample size and controlled design, yielding statistically significant results, though its short duration and focus on a single population group were noted limitations.
https://www.herbalgram.org/resources/herbclip/issues/2017/bin_580/single-ingredient-clinical-trials-with-tulsi-systematic-review-of-the-evidence/ – This HerbClip summary provides an overview of the systematic review of single-ingredient clinical trials with Tulsi. It reiterates the findings of consistent favorable effects across various health outcomes and highlights the need for further large-scale, standardized RCTs to refine dosing and confirm long-term safety.